You are here: Welcome » Ventavia Research Group

This is an old revision of the document!


Ventavia Research Group, LLC

ABOUT

Allegations

Study to Evaluate the Safety and Efficacy of a Booster Dose of BNT162b2 Against COVID-19 in Participants ≥16 Years of Age https://clinicaltrials.gov/ct2/show/NCT04955626

A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults https://clinicaltrials.gov/ct2/show/NCT04816643

Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older https://clinicaltrials.gov/ct2/show/NCT04754594

Back to top